+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Visceral leishmaniasis and bronchial asthma: influence of steroid therapy in the development of the macrophage activation syndrome and relative adrenal insufficiency

Visceral leishmaniasis and bronchial asthma: influence of steroid therapy in the development of the macrophage activation syndrome and relative adrenal insufficiency

Anales de Medicina Interna 25(6): 279-283

The risk of suffering opportunistics infections in the immunoincompetent patient is a fact perfectly established. An uncommon situation constitutes the bronchopaties, pathologies with a high prevalence among the general population that they require habitually, among other, steroid treatment. The immunosupression confers to the clinical evolution of the infections, as a consequence of the inadequate response to the physical stress, due to the inhibition of the hypothalamus-hypophysis axis being able to in particularly serious cases, to develop the denominated macrophage activation syndrome, a serious and uncommon syndrome that darkens the clinical prognosis in these patients. In presence of a feverish syndrome of uncertain origin in a patient in immunosuppressor treatment, although it is to low dose, it is necessary to carry out a exhaustive differential diagnosis, should consider, among them, the infection for Leishmania, a parasitosis whose incidence is increasing notably in the last years in the immunosuppressed population. We present the clinical case of a 63 year-old patient, immunoincompetent as a consequence of secondary chronic steroid therapy to asthmatic bronchopaty that experiences an uncommon form of visceral leishmaniasis in our area, consistent in multiorganic failure in the context of the development of a macrophage activation syndrome.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 056877825

Download citation: RISBibTeXText

PMID: 19295975

Related references

Macrophage activation syndrome and autoimmunity due to visceral leishmaniasis. Archives de Pediatrie 22(4): 397-400, 2015

Visceral leishmaniasis leading to macrophage activation syndrome. Medecine et Maladies Infectieuses 2019, 2019

Syndrome of inappropriate macrophage activation associated with infantile visceral leishmaniasis. La Tunisie Medicale 77(12): 648-650, 2000

Severe macrophage activation syndrome following visceral leishmaniasis in a child. Medecine et Sante Tropicales 24(2): 221-223, 2015

Inappropriate macrophage activation syndrome associated with visceral leishmaniasis in an infant. Tunisie Medicale 77(12): 648-650, 1999

Visceral Leishmaniasis Associated with Macrophage Activation Syndrome and Diffuse Alveolar Hemorrhage in a Lupus Patient. Acta Medica Portuguesa 31(10): 593-596, 2018

Visceral leishmaniasis triggering (mimicking) macrophage activation syndrome in a patient with adult onset Still disease. Internal Medicine Journal 46(11): 1347-1348, 2016

Bronchial asthma and adrenal cortex functions (effects of steroid therapy. Bulletin of the Chest Disease Research Institute, Kyoto University 8(1): 26-33, 1974

Diagnosis of adrenal cortex insufficiency in steroid-dependent bronchial asthma--the CRH test in comparison with diurnal cortisol profile in serum and cortisol in 24-hour urine. Pneumologie 48(11): 793-798, 1994

Posterior reversible encephalopathy syndrome (PRES/RPLS) during pulse steroid therapy in macrophage activation syndrome. Indian Journal of Pediatrics 78(8): 1002-1004, 2012

Influence of steroid inhalation therapy on microorganism of respiratory infections in patients with bronchial asthma. Kansenshogaku Zasshi. Journal of the Japanese Association for Infectious Diseases 73(11): 1165-1166, 2000

Interpretation of relative adrenal insufficiency in asthma; variations of eosinophilia in asthma caused by certain disorders; autohemotherapy. Le Scalpel 110(9): 195-206, 1957

The influence of intractable bronchial asthma on growth of children in pre-steroid era and during therapy with cortisone, prednisone and betamethasone. Excerpta Med Internatl Congr Ser:, 1961

The overuse of steroid therapy in bronchial asthma; report of case of iatrogenic Cushing's syndrome due to corticotropin. Minnesota Medicine 41(6): 399-402, 1958

Adrenal insufficiency in bronchial asthma. Vutreshni Bolesti 18(1): 59-63, 1979